Cargando…
Who Should Be Considered for Islet Transplantation Alone?
PURPOSE OF REVIEW: Episodic hypoglycemia is an almost inevitable consequence of exogenous insulin treatment of type 1 diabetes, and in up to 30% of patients, this can lead to impaired awareness of hypoglycemia. This predisposes to recurrent severe hypoglycemia and has a huge impact on quality of lif...
Autores principales: | Othonos, Nantia, Choudhary, Pratik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350263/ https://www.ncbi.nlm.nih.gov/pubmed/28293906 http://dx.doi.org/10.1007/s11892-017-0847-6 |
Ejemplares similares
-
Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
por: AlRashidi, Fatimah T., et al.
Publicado: (2018) -
Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?
por: Venkatanarasimhamoorthy, Vishnu Swaroop, et al.
Publicado: (2018) -
Therapeutic Strategies for Modulating the Extracellular Matrix to Improve Pancreatic Islet Function and Survival After Transplantation
por: Smink, Alexandra M., et al.
Publicado: (2018) -
Pancreas-on-a-Chip Technology for Transplantation Applications
por: Abadpour, Shadab, et al.
Publicado: (2020) -
Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?
por: Leemkuil, M., et al.
Publicado: (2019)